These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8443764)

  • 1. Flow cytometric (DNA content and S-phase fraction) analysis of breast cancer.
    Batsakis JG; Sneige N; el-Naggar AK
    Cancer; 1993 Mar; 71(6 Suppl):2151-3. PubMed ID: 8443764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-color, cytokeratin-labeled dna flow cytometric analysis of 332 breast cancers: lack of prognostic value with 12-year follow-up.
    Prasad AR; Divine G; Zarbo RJ
    Arch Pathol Lab Med; 2001 Mar; 125(3):364-74. PubMed ID: 11231485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammographic growth rate, DNA ploidy, and S-phase fraction analysis in breast carcinoma. A prognostic evaluation in a screened population.
    Arnerlöv C; Emdin SO; Lundgren B; Roos G; Söderström J; Bjersing L; Norberg C; Angquist KA
    Cancer; 1992 Oct; 70(7):1935-42. PubMed ID: 1525769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA flow cytometric analysis and prognosis of axillary lymph node-negative breast carcinoma.
    Bosari S; Lee AK; Tahan SR; Figoni MA; Wiley BD; Heatley GJ; Silverman ML
    Cancer; 1992 Oct; 70(7):1943-50. PubMed ID: 1525770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast carcinoma growth rate described by mammographic doubling time and S-phase fraction. Correlations to clinical and histopathologic factors in a screened population.
    Arnerlöv C; Emdin SO; Lundgren B; Roos G; Söderström J; Bjersing L; Norberg C; Angquist KA
    Cancer; 1992 Oct; 70(7):1928-34. PubMed ID: 1525768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell cycle analysis of 932 flow cytometric DNA histograms of fresh frozen breast carcinoma material. Correlations between flow cytometric, clinical, and pathologic variables. MMMCP Collaborative Group. Multicenter Morphometric Mammary Carcinoma Project Collaborative Group.
    Bergers E; van Diest PJ; Baak JP
    Cancer; 1996 Jun; 77(11):2258-66. PubMed ID: 8635093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S-phase fraction and nuclear size in long term prognosis of patients with breast cancer.
    Meyer JS; Province MA
    Cancer; 1994 Oct; 74(8):2287-99. PubMed ID: 7922981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of S-phase fraction in lymph-node-negative breast cancer by image and flow cytometric analysis.
    Peiró G; Lerma E; Climent MA; Seguí MA; Alonso MC; Prat J
    Mod Pathol; 1997 Mar; 10(3):216-22. PubMed ID: 9071729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AgNORs in ductal breast cancer: correlation with ploidy and S-phase fraction by DNA flow cytometry.
    Borgiani L; Cogorno P; Oliviero J; Toso F; Gambini G; Tunesi G; Canepa M
    Eur J Histochem; 1994; 38(2):171-6. PubMed ID: 7524814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ploidy analysis and S-phase fraction determination by flow cytometry of invasive adenocarcinomas of the breast.
    Frierson HF
    Am J Surg Pathol; 1991 Apr; 15(4):358-67. PubMed ID: 2006715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can we identify the group of small invasive (T1a,b) breast cancers with minimal risk of axillary lymph node involvement? A pathohistological and DNA flow cytometric study.
    Bezić J; Samija-Projić I; Projić P; Ljubković J; Capkun V; Tomić S
    Pathol Res Pract; 2011 Jul; 207(7):438-42. PubMed ID: 21689895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric DNA index and S-phase fraction in breast cancer in relation to other prognostic variables and to clinical outcome.
    Fernö M; Baldetorp B; Borg A; Olsson H; Sigurdsson H; Killander D
    Acta Oncol; 1992; 31(2):157-65. PubMed ID: 1622630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Epithelial growth factor receptors (EGF-R) and DNA flow cytometry in addition to lymph node and hormone receptor status as prognostic factors in primary breast cancer].
    Costa SD; Kaufmann M; Fabbro D; Tokus M; Feichter G; Klinga K; Bastert G
    Geburtshilfe Frauenheilkd; 1989 Apr; 49(4):375-8. PubMed ID: 2544476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Static and flow cytometric DNA analysis compared to histologic prognostic factors in a cohort of stage T2 breast cancer.
    Arnerlöv C; Emdin SO; Roos G; Angström T; Bjersing L; Angquist KA; Jonsson H
    Eur J Surg Oncol; 1990 Jun; 16(3):200-8. PubMed ID: 2347415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA ploidy and percent S-phase as prognostic factors in node-positive breast cancer: results from patients enrolled in two prospective randomized trials.
    Witzig TE; Ingle JN; Schaid DJ; Wold LE; Barlow JF; Gonchoroff NJ; Gerstner JB; Krook JE; Grant CS; Katzmann JA
    J Clin Oncol; 1993 Feb; 11(2):351-9. PubMed ID: 8426213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Image cytometric DNA analysis in human breast cancer analysis may add prognostic information in diploid cases with low S-phase fraction by flow cytometry.
    Baldetorp B; Fernö M; Fallenius A; Fallenius-Vecchi G; Idvall I; Olsson H; Sigurdsson H; Akerman M; Killander D
    Cytometry; 1992; 13(6):577-85. PubMed ID: 1451590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of morphological parameters and flow cytometric DNA analysis in carcinoma of the breast.
    Visscher DW; Zarbo RJ; Greenawald KA; Crissman JD
    Pathol Annu; 1990; 25 Pt 1():171-210. PubMed ID: 2153277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of prognostic factors following flow-cytometric DNA analysis after cytokeratin labelling: I. Breast cancer.
    Wimberger P; Hillemanns P; Kapsner T; Hepp H; Kimmig R
    Anal Cell Pathol; 2002; 24(4-5):135-45. PubMed ID: 12590150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An image cytometric DNA-analysis in breast neoplasms. Parameters of DNA-aneuploidy and their relationship with conventional prognostic factors.
    Longin A; Fontanière B; Pinzani V; Catimel G; Souchier C; Clavel M; Chauvin F
    Pathol Res Pract; 1992 Jun; 188(4-5):466-72. PubMed ID: 1409073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA flow cytometric measurements in breast cancer: a review of the instrumentation principles and clinical significance.
    Berho M; Viciana AL; Poppiti RJ; Ruiz P
    J Fla Med Assoc; 1997 Feb; 84(2):104-10. PubMed ID: 9066236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.